News
today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval Supplement (PAS) to the supplemental biologics license application (sBLA) for EGRIFTA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results